Lin Shao-Lee bought CUE
May 3, 2026 · Form 4 insider transaction
Lin Shao-Lee bought 655,074 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
655,074
Price
$0.00
Total value
N/A
InsiderLin Shao-Lee
RoleOfficer, Director
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 3, 2026
Filing dateMay 7, 2026
Shares owned after655,074
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option becomes exercisable in 48 equal monthly installments beginning on April 30, 2026.